Skip to main content
Caplight Logo









Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals

Private
ShanghaiHealthcare & Life Scienceshttps://www.sanyoubio.com/

Last Round

Series B

Extension

Aug 2, 2022

Total Funding Raised

$5.78M

Company Overview

Sanyou Biopharmaceuticals is a biotechnology company that provides contract research, development, and manufacturing organization (CRDMO) services for innovative biologic and antibody drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROantibody drug discoveryAI drug discoverycontract development organizationCDOantibody discovery platformbiologics discoveryAI biotechpreclinical developmentantibody engineeringcomputational drug discoverycell line developmentin vivo efficacy evaluationin vitro efficacy evaluationcollaborative project organizationCPO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sanyou Biopharmaceuticals Comparables

Compare Sanyou Biopharmaceuticals with similar companies based on industry and business-model similarity.

Sanyou Biopharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FairJourney Biologics
82%
BigHat Biosciences
81%
AbCellera
78%

Sanyou Biopharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 2, 2022
Series BJun 26, 2021
Series AMay 16, 2020

Key People

Founding team and executive leadership

David Lang

Founder & CEO

Founding Team

Sanyou Biopharmaceuticals Investors

Notable investors and investment history

Sanyou Biopharmaceuticals investors
InvestorRounds
Huatai Zijin InvestmentSeries B Extension
Grand Mount CapitalSeries B
Linghang VenturesSeries B Extension, Series B
Huatai Zijin InvestmentSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 164% MoM.

  • Jan 1, 2026

    Monthly visitors increased 210% MoM, reaching 784.

Sanyou Biopharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sanyou Biopharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sanyou Biopharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range162
Year Founded2015
Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?